Phase 2 study of daratumumab in NHL won’t proceedMarch 31, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
CHMP recommends drug for relapsed/refractory cHLMarch 25, 2017Lymphoma & Plasma Cell DisordersPharmacyHodgkin LymphomaAggressive Lymphomas
Most blood cancer mutations due to DNA replication errorsMarch 24, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Preterm births more common in cancer survivorsMarch 24, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Therapy can produce durable CRs in NHLMarch 17, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Veterans don’t have higher risk of leukemia, lymphomaMarch 15, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
FDA approves pembrolizumab to treat cHLMarch 15, 2017Lymphoma & Plasma Cell DisordersPharmacyHodgkin LymphomaAggressive Lymphomas
Family history impacts risk of second cancer after HLMarch 14, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaAggressive Lymphomas
Selinexor trials placed on partial holdMarch 14, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyAMLNon-Hodgkin LymphomaAggressive Lymphomas
Drug receives orphan designation for DLBCLMarch 13, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Study confirms increased adiposity in HSCT survivorsMarch 11, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantationAggressive Lymphomas
Potential therapeutic strategy for BL, DLBCLMarch 2, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
CCSs’ subsequent cancer risk decreased from ’70s to ’90sMarch 1, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsAggressive Lymphomas
Drug granted orphan status for follicular lymphomaFebruary 24, 2017Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
Factors linked to B-NHL in Palestinians, IsraelisFebruary 23, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
